Weight Loss Breakthrough: Stanford Scientists Discover "Natural Ozempic" Without the Side Effects

Full Article
Weight Loss Breakthrough: Stanford Scientists Discover

Stanford researchers have identified a naturally occurring molecule named BRP that effectively reduces appetite and body weight in animals, similar to the effects of semaglutide (Ozempic), but without the associated side effects like nausea and muscle loss. This discovery was facilitated by artificial intelligence, which helped pinpoint BRP from a pool of prohormones, indicating its potential as a more targeted obesity treatment. The research highlights BRP's unique action in the hypothalamus, differentiating it from semaglutide's broader effects on various body systems.

The study, published in Nature, showcases the innovative use of AI in biomedical research, particularly through the development of the Peptide Predictor algorithm. This algorithm enabled researchers to analyze a vast array of proteins and identify biologically active peptides, leading to the discovery of BRP. The findings suggest a promising avenue for obesity treatment, with clinical trials for human applications anticipated in the near future.

• AI was used to identify the appetite-reducing molecule BRP.

• Peptide Predictor algorithm facilitated the discovery of biologically active peptides.

Key AI Terms Mentioned in this Article

Artificial Intelligence

Artificial intelligence was crucial in analyzing proteins to discover the BRP molecule.

Peptide Predictor

Peptide Predictor is an algorithm designed to identify prohormone cleavage sites in proteins.

Companies Mentioned in this Article

Merrifield Therapeutics

Merrifield Therapeutics is co-founded by a researcher involved in the BRP clinical trials.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 7month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 7month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 7month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 7month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics